Litcius/Paper detail

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group

2021Repository@Nottingham (University of Nottingham)1,078 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTocilizumabRandomized controlled trialOxygen therapyInternal medicinePopulationCoronavirus disease 2019 (COVID-19)Clinical trialIntention-to-treat analysisEnvironmental healthDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Intensive Care Unit Cognitive Disorders
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. | Litcius